Tilray, a Canadian pharmaceutical, and cannabis company, and Privateer, an American private equity company that invests in the legal cannabis industry, completed the merger deal. “We appreciate the long-term confidence that Privateer has in the Tilray business and we look forward to having their investors as part of our stockholder base. We believe this transaction will give Tilray greater control and operating flexibility while allowing us to effectively manage our public float,” Mark Castaneda, Tilray CFO.